RACHEL DECOSTER: Open Payments
NPI 1871902957 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 66 payments from 12 companies in 2025. Trend: 2023 $1,375 · 2024 $1,357 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $260 |
| GlaxoSmithKline, LLC. | 10 | $163 |
| Insulet Corporation | 6 | $115 |
| Lilly USA, LLC | 6 | $99 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| PFIZER INC. | 5 | $82 |
| Novo Nordisk Inc | 4 | $70 |
| Abbott Laboratories | 3 | $53 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: TRELEGY ELLIPTA, Omnipod, VRAYLAR, UBRELVY, LEQVIO, NURTEC ODT, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
